Kazia Therapeutics Limited Skyrocketed
Fri, Nov 13, 2020 at 05:30 PM
Kazia Therapeutics Limited (KZIA:NASDAQ) shot up at $10.05, representing a gain of 30%. On Thu 12 Nov 20, KZIA:NASDAQ hit a New 2-Week High of $7.73. The stock appeared on our News Catalysts scanner on Tue 10 Nov 20 at 08:38 AM in the 'AGREEMENT' category. From Thu 29 Oct 20, the stock recorded 80.00% Up Days and 45.45% Green Days
About Kazia Therapeutics Limited (KZIA:NASDAQ)
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, engaged in developing anti-cancer drugs. It has two clinical staged drug development candidates and an early stage discovery program.
Top 10 Gainers:
- Urovant Sciences Ltd. (UROV:NASDAQ), 93.48%
- CBAK Energy Technology, Inc. (CBAT:NASDAQ), 54.91%
- Asia Pacific Wire & Cable Corporation Limited (APWC:NASDAQ), 47.73%
- National Holdings Corporation (NHLD:NASDAQ), 42.41%
- KCAC (KCAC:NYSE), 36.36%
- Electrameccanica Vehicles Corp. (SOLO:NASDAQ), 30.23%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 30.01%
- Dragon Victory International Limited (LYL:NASDAQ), 28.97%
- ReneSola Ltd (SOL:NYSE), 28.46%
- BSQUARE Corporation (BSQR:NASDAQ), 25.64%